# The Effect of Therapeutic Hypothermia on Ischemic Brain Injury in a Rat Model of Cardiac Arrest: An Assessment Using 18F-FDG PET

**Authors:** Daehee Kim, Woon Jeong Lee, Seon Hee Woo, Hye Won Lee, Bom Sahn Kim, Hai-Jeon Yoon

PMC · DOI: 10.3390/diagnostics14151674 · Diagnostics · 2024-08-02

## TL;DR

This study investigates how therapeutic hypothermia affects brain glucose metabolism in rats after cardiac arrest, finding benefits only in those with severe brain injury.

## Contribution

The study reveals that therapeutic hypothermia improves brain glucose metabolism only in rats with severe encephalopathy.

## Key findings

- Survival rates were the same in both hypothermia and non-hypothermia groups.
- Hypothermia increased glucose metabolism in cortical regions of non-surviving rats with severe encephalopathy.
- Benefits of hypothermia were not observed in surviving rats or overall cortical regions.

## Abstract

Purpose: Therapeutic hypothermia (TH) is widely acknowledged as one of the interventions for preventing hypoxic ischemic brain injury in comatose patients following cardiac arrest (CA). Despite its recognized efficacy, recent debates have questioned its effectiveness. This preclinical study evaluated the impact of TH on brain glucose metabolism, utilizing fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in a rat model of CA. Methods: Asphyxia CA was induced in Sprague-Dawley rats using vecuronium. Brain PET images using 18F-FDG were obtained from 21 CA rats, who were randomized to receive either TH or no intervention. Of these, 9 rats in the TH group received hypothermia under general anesthesia and mechanical ventilation for eight hours, while the remaining 12 rats in the non-TH group were observed without intervention. We conducted regional and voxel-based analyses of standardized uptake values relative to the pons (SUVRpons) to compare the two groups. Results: Survival rates were identical in both the TH and non-TH groups (67%). There was no discernible difference in the SUVRpons across the brain cortical regions between the groups. However, in a subgroup analysis of the rats that did not survive (n = 7), those in the TH group (n = 3) displayed significantly higher SUVRpons values across most cortical regions compared to those in the non-TH group (n = 4), with statistical significance after false-discovery rate correction (p < 0.05). Conclusions: The enhancement in SUVRpons due to TH intervention was only observed in the cortical regions of rats with severe encephalopathy that subsequently died. These findings suggest that the beneficial effects of TH on brain glucose metabolism in this asphyxia CA model may be confined to cases of severe ischemic encephalopathy.

## Linked entities

- **Chemicals:** 18F-FDG (PubChem CID 68614)
- **Diseases:** cardiac arrest (MONDO:0000745), encephalopathy (MONDO:0005560)

## Full-text entities

- **Diseases:** encephalopathy (MESH:D001927), comatose (MESH:D003128), Ischemic Brain Injury (MESH:D001930), died (MESH:D003643), Hypothermia (MESH:D007035), Asphyxia CA (MESH:D006323), hypoxic ischemic brain injury (MESH:D020925), ischemic encephalopathy (MESH:D002545)
- **Chemicals:** 18F-FDG (MESH:D019788), vecuronium (MESH:D014673), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11311465/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11311465/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC11311465/full.md

---
Source: https://tomesphere.com/paper/PMC11311465